Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers
NCT ID: NCT02101723
Last Updated: 2018-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2011-04-30
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods
NCT01111864
Effectiveness of Selling Micronutrient Sprinkles in Rural Kenya
NCT01088958
Zinc Bioavailability From Amaranth-enriched Maize Tortillas
NCT02208609
Effect of Timing of Micronutrient Powder Consumption on Iron Absorption in Infants
NCT02989311
Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of Anemia
NCT00210405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Characterizing the impact of enteral iron administration on the evolution of the intestinal microbiome in infants from 6 to 9 months of age.
2. Characterizing iron administration-associated inflammatory responses and correlate these with changes in the intestinal microbiome in infants from 6 to 9 months of age. Specifically, changes in the microbiome will be correlated with biomarkers reflecting:
1. Intestinal inflammation;
2. Systemic inflammation, bacterial translocation, and oxidant stress;
3. Iron status and homeostasis
3. Quantify to what degree Fe interferes with Zn absorption (TAZ) and how it affects the size of the infant's exchangeable zinc pool (EZP).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Micronutrient Powder (MNP) + Zn/Fe
Micronutrient Powder with 5 mg Zn and 12 mg Fe
MNP + Zn/Fe
Micronutrient powder with 12 mg Fe and 5 mg Zn provided daily from 6-9 months of age
MNP + Zn
Micronutrient Powder with 5 mg Zn
MNP + Zn
Micronutrient powder with 5 mg Zn provided daily from 6-9 months of age
Control
Placebo sachets without micronutrients
Placebo
Placebo powder without micronutrients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MNP + Zn/Fe
Micronutrient powder with 12 mg Fe and 5 mg Zn provided daily from 6-9 months of age
MNP + Zn
Micronutrient powder with 5 mg Zn provided daily from 6-9 months of age
Placebo
Placebo powder without micronutrients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Birthweight \> 2500 g
* Healthy with no apparent congenital anomalies
* Up-to-date with vaccinations
* Hb \>10 g/dL
* Breastfeeding with intent to continue for duration of study
* Negative blood slide for malaria
* Written informed consent
Exclusion Criteria
* Current or anticipated used of infant formula or other fortified products
* Current or planned use of iron (or zinc) supplements
* Previous hospitalization for malaria within the last four weeks
* Persistent diarrhea
5 Months
10 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
International Atomic Energy Agency
OTHER_GOV
Moi University
OTHER
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy F Krebs, MD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Fabian Esamai, MD
Role: STUDY_DIRECTOR
Moi Univeristy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Denver
Aurora, Colorado, United States
Moi University
Eldoret, , Kenya
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Esamai F, Liechty E, Ikemeri J, Westcott J, Kemp J, Culbertson D, Miller LV, Hambidge KM, Krebs NF. Zinc absorption from micronutrient powder is low but is not affected by iron in Kenyan infants. Nutrients. 2014 Dec;6(12):5636-51. doi: 10.3390/nu6125636.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15827
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
16933
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
11-0227
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.